Blends neuroscience with rehabilitation robotics, pioneering brain-computer interfaces and neuro-rehab systems. Bridges scientific discovery and clinical outcomes for stroke and neurological recovery patients.

Targets diabetes, obesity, and metabolic disease with differentiated long-acting GLP-1 receptor agonists. Core product PB-119 is NDA-stage, leading China's innovative approach to chronic disease prevention.

Pioneers in vivo CRISPR/Cas9 gene editing via proprietary VLP and lentiviral delivery platforms. Lead program BD111 — the world's first CRISPR antiviral therapeutic targeting herpetic stromal keratitis — holds FDA IND clearance, Phase II clinical status, and EU Orphan Drug Designation.

Develops high-speed, high-reliability chips for optical communication and data centers. Supports 400G+ data infrastructures essential for cloud computing and AI scalability.

Delivers real-time diagnostics for high-voltage electrical systems in substations and factories. Addresses critical infrastructure safety and operational continuity across industrial environments.

Offers human-machine intelligence solutions for China's Industry 4.0 evolution, linking data, machines, and people. Also serves hospital and manufacturing clients with digital health infrastructure.

China's fifth-largest digital retail solutions provider by GMV. End-to-end services from traffic to fulfillment for 200+ global brands across Tmall, JD.com, Douyin, and Pinduoduo.

EU-based premium health supplement brand with 4M+ customers across 40+ countries. Expanding into the China market through a strategic partnership with Leapsun.